We are live on ! Find out more
RA

Royce & Associates Portfolio holdings

AUM $10.1B
1-Year Est. Return 42.88%
This Fund
S&P 500
This Quarter Est. Return
+3.5%
1 Year Est. Return
+42.88%
3 Year Est. Return
+92.52%
5 Year Est. Return
+113.84%
10 Year Est. Return
+608.05%
AUM
$10.8B
AUM Growth
-$222M
Cap. Flow
-$287M
Cap. Flow %
-2.66%
Top 10 Hldgs %
9.23%
Holding
920
New
57
Increased
332
Reduced
337
Closed
91

Top Buys

Rank Stock Value
1
LCII icon
LCI Industries
LCII
+$19.9M
2
KWR icon
Quaker Houghton
KWR
+$19.1M
3
FORM icon
FormFactor
FORM
+$17.5M
4
AMSF icon
AMERISAFE
AMSF
+$16.5M
5
TKR icon
Timken Company
TKR
+$16.3M

Sector Composition

Rank Sector Weight
1 Industrials 25.23%
2 Technology 19.83%
3 Financials 14.91%
4 Consumer Discretionary 12.13%
5 Healthcare 8.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PAYS icon
826
Paysign
PAYS
$517M
$42.7K ﹤0.01%
14,153
-207,558
-94% -$728K
OLPX
827
DELISTED
Olaplex Holdings
OLPX
$36.8K ﹤0.01%
21,297
-46,485
-69% -$92.5K
METCB icon
828
Ramaco Resources Class B
METCB
$423M
$18.9K ﹤0.01%
+2,014
New +$19.5K
IPW icon
829
iPower
IPW
$1.08M
$11.1K ﹤0.01%
56
-4
-7% -$1.16K
AEO icon
830
American Eagle Outfitters
AEO
$2.94B
-29,343
Closed -$657K
ALE
831
DELISTED
Allete
ALE
-3,141
Closed -$202K
APPS icon
832
Digital Turbine
APPS
$982M
-241,500
Closed -$741K
ARAY icon
833
Accuray
ARAY
$27.5M
-1,882,369
Closed -$3.39M
ARCT icon
834
Arcturus Therapeutics
ARCT
$165M
-155,803
Closed -$3.62M
ASIX icon
835
AdvanSix
ASIX
$542M
-12,914
Closed -$392K
ASRT
836
DELISTED
Assertio
ASRT
-5,054
Closed -$89.5K
CVSA
837
Covista Inc
CVSA
$4.55B
-5,768
Closed -$435K
ATNM icon
838
Actinium Pharmaceuticals
ATNM
$26.3M
-50,000
Closed -$94K
BBDC icon
839
Barings BDC
BBDC
$869M
-215,300
Closed -$2.11M
BIOX icon
840
Bioceres Crop Solutions
BIOX
$20.6M
-229,147
Closed -$1.8M
BOOM icon
841
DMC Global
BOOM
$111M
-277,705
Closed -$3.6M
BRAG
842
Bragg Gaming Group
BRAG
$42.2M
-114,800
Closed -$582K
BTU icon
843
Peabody Energy
BTU
$2.54B
-8,393
Closed -$223K
BW icon
844
Babcock & Wilcox
BW
$1.18B
-1,472,854
Closed -$3M
CAR icon
845
Avis
CAR
$5.47B
-2,481
Closed -$217K
CG icon
846
Carlyle Group
CG
$16.1B
-76,020
Closed -$3.27M
CHGG icon
847
Chegg
CHGG
$116M
-51,666
Closed -$91.4K
CLAR icon
848
Clarus
CLAR
$125M
-254,903
Closed -$1.15M
CRBU icon
849
Caribou Biosciences
CRBU
$146M
-142,912
Closed -$280K
CRDO icon
850
Credo Technology Group
CRDO
$33.1B
-55,000
Closed -$1.69M

Similar funds

Royce & Associates's Q4 2024 Portfolio in Review

As of Q4 2024, Royce & Associates held 920 positions worth $10.8B, down 2% from $11B the previous quarter. Its ten largest holdings account for 9.2% of the portfolio.

Royce & Associates's Q4 2024 filing shows 57 new, 332 increased, 337 reduced and 91 closed positions. Its largest new stake was AMERISAFE: 305,361 shares worth $15.7M. The largest sale was Ziff Davis, an estimated $33.8M.

By sector, the portfolio is most concentrated in Industrials at 25% of assets, down from 27% a quarter earlier, followed by Technology and Financials.

  • Royce & Associates's largest Q4 2024 buy was AMERISAFE: 305,361 shares worth $15.7M.
  • Royce & Associates added most to LCI Industries in Q4 2024, an estimated $19.9M increase.
  • Royce & Associates's biggest Q4 2024 reduction was Ziff Davis, cutting an estimated $33.8M.
  • Royce & Associates fully exited Carter's in Q4 2024, selling an estimated $13.1M.
  • Royce & Associates's ten largest holdings make up 9.2% of its $10.8B portfolio in Q4 2024.
  • Royce & Associates opened 57 new positions and closed 91 in Q4 2024.
  • Royce & Associates's portfolio value fell 2% quarter-over-quarter to $10.8B.

Based on Royce & Associates's 13F filing for Q4 2024, filed 10 Feb 2025.